Gastrointestinal stromal tumours - sunitinib: review decision - January 2012 information
History
Documents created during the development process.
Background information
-
-
Appendix A: decision paper presented to the Institute's Guidance Executive
-
Appendix A: decision paper presented to the Institute's Guidance Executive (PDF 74 KB)
-
Gastrointestinal stromal tumours - sunitinib: review update - November 2011 information
-
Appendix A: provisional matrix of stakeholders
-
-
Appendix B: proposal paper presented to the Institute's Guidance Executive
-
Appendix B: proposal paper presented to the Institute's Guidance Executive (PDF 101 KB)
Gastrointestinal stromal tumours - sunitinib: final appraisal determination
-
Gastrointestinal stromal tumours - sunitinib: final appraisal determination information
-
Gastrointestinal stromal tumours - sunitinib: final appraisal determination
-
Gastrointestinal stromal tumours - sunitinib: final appraisal determination (PDF 99 KB)
-
Response to consultee, commentator and public comments on the ACD and comments from website consultation
-
-
Consultee and commentator comments on the ACD
-
Sarcoma UK, Rarer Cancers Forum and GIST Support UK joint submission
-
Sarcoma UK, Rarer Cancers Forum and GIST Support UK joint submission (PDF 91 KB)
-
Royal College of Nursing
-
-
Pfizer
-
-
Peninsula Technology Assessment Group
-
-
Department of Health
-
-
Professor Ian Judson
-
Gastrointestinal stromal tumours - sunitinib: appraisal consultation
-
Gastrointestinal stromal tumours - sunitinib: appraisal consultation
-
Gastrointestinal stromal tumours - sunitinib: appraisal consultation document information
-
Gastrointestinal stromal tumours - sunitinib: evaluation report
-
Pre-meeting briefing
-
-
Evidence Review Group report
-
-
Evidence Review Group additional notes for the ACD meeting
-
Evidence Review Group additional notes for the ACD meeting (PDF 23 KB)
-
Non-manufacturer submissions
-
Association of Upper GI Surgeons of GB and NI
-
-
Plymouth PCT
-
-
Royal College of Physicians
-
-
Royal College of Nursing
-
-
Sarcoma UK/GIST Support UK
-
-
Pfizer
-
-
Expert written personal statements
-
Pendleton
-
-
Novelli
-
GIST - sunitinib: final scope
-
GIST - sunitinib: final scope
-
GIST - sunitinib: response to consultee and commentator comments on the draft scope
-
GIST - sunitinib: response to consultee and commentator comments on the draft scope
-
GIST - sunitinib: response to consultee and commentator comments on the draft scope (PDF 99 KB)
GIST - sunitinib: response to consultee and commentator comments on the provisional matrix
-
GIST - sunitinib: response to consultee and commentator comments on the provisional matrix
-